vs
Side-by-side financial comparison of Enpro Inc. (NPO) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). Enpro Inc. runs the higher net margin — -10.8% vs -82.0%, a 71.1% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs -22.7%). Over the past eight quarters, Enpro Inc.'s revenue compounded faster (7.1% CAGR vs -11.5%).
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
NPO vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.4M | $164.7M |
| Net Profit | $-32.0M | $-135.0M |
| Gross Margin | 42.1% | — |
| Operating Margin | 11.2% | -43.3% |
| Net Margin | -10.8% | -82.0% |
| Revenue YoY | 14.3% | -22.7% |
| Net Profit YoY | -330.2% | -104.8% |
| EPS (diluted) | $-1.50 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.4M | $164.7M | ||
| Q3 25 | $286.6M | $211.0M | ||
| Q2 25 | $288.1M | $178.9M | ||
| Q1 25 | $273.2M | $1.2B | ||
| Q4 24 | $258.4M | $213.2M | ||
| Q3 24 | $260.9M | $196.8M | ||
| Q2 24 | $271.9M | $186.7M | ||
| Q1 24 | $257.5M | $210.1M |
| Q4 25 | $-32.0M | $-135.0M | ||
| Q3 25 | $21.6M | $15.9M | ||
| Q2 25 | $26.4M | $-64.8M | ||
| Q1 25 | $24.5M | $866.6M | ||
| Q4 24 | $13.9M | $-65.9M | ||
| Q3 24 | $19.8M | $-106.7M | ||
| Q2 24 | $26.7M | $-99.2M | ||
| Q1 24 | $12.5M | $-91.6M |
| Q4 25 | 42.1% | — | ||
| Q3 25 | 41.9% | — | ||
| Q2 25 | 43.3% | — | ||
| Q1 25 | 43.3% | — | ||
| Q4 24 | 42.3% | — | ||
| Q3 24 | 42.3% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 41.2% | — |
| Q4 25 | 11.2% | -43.3% | ||
| Q3 25 | 14.3% | 1.4% | ||
| Q2 25 | 15.9% | -19.5% | ||
| Q1 25 | 15.3% | 82.5% | ||
| Q4 24 | 12.5% | -76.2% | ||
| Q3 24 | 13.1% | -27.7% | ||
| Q2 24 | 17.7% | -21.5% | ||
| Q1 24 | 10.9% | -21.6% |
| Q4 25 | -10.8% | -82.0% | ||
| Q3 25 | 7.5% | 7.5% | ||
| Q2 25 | 9.2% | -36.3% | ||
| Q1 25 | 9.0% | 73.7% | ||
| Q4 24 | 5.4% | -30.9% | ||
| Q3 24 | 7.6% | -54.2% | ||
| Q2 24 | 9.8% | -53.1% | ||
| Q1 24 | 4.9% | -43.6% |
| Q4 25 | $-1.50 | $-1.63 | ||
| Q3 25 | $1.01 | $0.20 | ||
| Q2 25 | $1.25 | $-0.83 | ||
| Q1 25 | $1.15 | $10.04 | ||
| Q4 24 | $0.65 | $-0.85 | ||
| Q3 24 | $0.94 | $-1.39 | ||
| Q2 24 | $1.27 | $-1.29 | ||
| Q1 24 | $0.59 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.7M | $1.9B |
| Total DebtLower is stronger | $655.3M | — |
| Stockholders' EquityBook value | $1.5B | $-205.3M |
| Total Assets | $2.7B | $2.9B |
| Debt / EquityLower = less leverage | 0.42× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.7M | $1.9B | ||
| Q3 25 | $132.9M | $1.7B | ||
| Q2 25 | $107.1M | $2.0B | ||
| Q1 25 | $240.3M | $2.0B | ||
| Q4 24 | $236.3M | $1.1B | ||
| Q3 24 | $206.9M | $1.0B | ||
| Q2 24 | $175.9M | $1.1B | ||
| Q1 24 | $163.9M | $884.8M |
| Q4 25 | $655.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $640.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $644.9M | — |
| Q4 25 | $1.5B | $-205.3M | ||
| Q3 25 | $1.5B | $-155.8M | ||
| Q2 25 | $1.5B | $-206.5M | ||
| Q1 25 | $1.5B | $-185.8M | ||
| Q4 24 | $1.4B | $-1.1B | ||
| Q3 24 | $1.5B | $-1.1B | ||
| Q2 24 | $1.4B | $-980.2M | ||
| Q1 24 | $1.4B | $-893.9M |
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.4B | $2.6B | ||
| Q1 25 | $2.5B | $2.7B | ||
| Q4 24 | $2.5B | $1.7B | ||
| Q3 24 | $2.5B | $1.8B | ||
| Q2 24 | $2.5B | $1.9B | ||
| Q1 24 | $2.5B | $1.8B |
| Q4 25 | 0.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.46× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | 4.1% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $65.3M | $-66.3M | ||
| Q2 25 | $52.2M | $-58.3M | ||
| Q1 25 | $21.0M | $870.1M | ||
| Q4 24 | $59.4M | $-30.0M | ||
| Q3 24 | $54.0M | $-77.0M | ||
| Q2 24 | $43.2M | $-71.5M | ||
| Q1 24 | $6.3M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | $53.4M | $-69.7M | ||
| Q2 25 | $42.3M | $-59.6M | ||
| Q1 25 | $13.0M | $868.4M | ||
| Q4 24 | $49.1M | $-33.8M | ||
| Q3 24 | $48.3M | $-77.5M | ||
| Q2 24 | $38.3M | $-78.8M | ||
| Q1 24 | $-1.9M | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | 18.6% | -33.1% | ||
| Q2 25 | 14.7% | -33.3% | ||
| Q1 25 | 4.8% | 73.8% | ||
| Q4 24 | 19.0% | -15.8% | ||
| Q3 24 | 18.5% | -39.4% | ||
| Q2 24 | 14.1% | -42.2% | ||
| Q1 24 | -0.7% | 29.1% |
| Q4 25 | 4.1% | 1.4% | ||
| Q3 25 | 4.2% | 1.6% | ||
| Q2 25 | 3.4% | 0.7% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 4.0% | 1.8% | ||
| Q3 24 | 2.2% | 0.3% | ||
| Q2 24 | 1.8% | 4.0% | ||
| Q1 24 | 3.2% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 3.02× | -4.17× | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 0.86× | 1.00× | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 2.73× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
PTCT
Segment breakdown not available.
